Olaplex reported a 4.3% increase in net sales for Q4 2025, driven by strong growth in the Professional and Direct-To-Consumer channels, despite a decline in Specialty Retail. However, the company experienced a wider net loss of $13.1 million compared to the prior year, primarily due to increased SG&A expenses and litigation-related costs.

Olaplex experienced a challenging third quarter in 2025 with a 3.8% decrease in net sales to $114.6 million and a significant 24.8% drop in net income to $11.1 million. Despite these declines, the company reaffirmed its annual guidance, citing investments in sales and marketing, improved executional capabilities, and early positive results from new product introductions.

Olaplex delivered a solid first half of 2025, with net sales increasing by 2.3% to $106.3 million in Q2 2025 compared to the prior year. However, the company reported a net loss of $7.7 million and diluted EPS of ($0.01) for the quarter, a significant decrease from net income in Q2 2024.

Olaplex reported a solid start to the year with first quarter net sales of $97.0 million, slightly ahead of expectations despite a 1.9% decrease year-over-year. Net income significantly decreased to $0.5 million compared to $7.7 million in the prior year, resulting in diluted EPS of $0.00. The company reiterated its full-year fiscal 2025 guidance.

Olaplex's Q4 2024 revenue fell 9.8% year-over-year to $100.7 million. The company reported a net loss of $8.8 million compared to a net income of $14.1 million in Q4 2023. Specialty Retail revenue increased, while Professional and Direct-To-Consumer sales declined. Gross profit margin declined slightly due to increased SG&A expenses.

Olaplex reported a 3.6% decrease in net sales to $119.1 million and a 27.3% decrease in net income for the third quarter of 2024. The company has revised its fiscal year 2024 guidance due to the realignment of its international business and weaker performance than anticipated.

Olaplex reported second quarter 2024 results with net sales decreasing by 4.8% to $103.9 million compared to the second quarter of 2023. Diluted EPS was $0.01, and Adjusted Diluted EPS was $0.03. The company is reiterating guidance for net sales, adjusted net income and adjusted EBITDA for fiscal year 2024.

Olaplex reported a decrease in net sales by 13.1% to $98.9 million compared to Q1 2023. Diluted EPS was $0.01, and adjusted diluted EPS was $0.03. The company is reiterating its fiscal year 2024 guidance for net sales, adjusted net income, and adjusted EBITDA.

Olaplex reported a net sales decrease of 14.5% to $111.7 million in Q4 2023 compared to Q4 2022. Diluted EPS was $0.02, and adjusted diluted EPS was $0.03.

Olaplex reported a 30.0% decrease in net sales to $123.6 million and a 66.5% decrease in net income to $20.4 million compared to Q3 2022. The company's interim CEO cited encouraging early indicators from increased investments and ongoing efforts to stabilize sales and position the brand for long-term profitable growth.

Olaplex reported a 48.2% decrease in net sales to $109.2 million for Q2 2023 compared to Q2 2022. Net income decreased significantly to $6.2 million, and diluted EPS was $0.01. The company has revised its fiscal year 2023 guidance downward due to weaker than expected results and lower baseline demand.

Olaplex reported net sales of $113.8 million, a decrease of 38.9% compared to the first quarter of 2022. The company's performance was impacted by lower demand for core products, inventory rebalancing at professional and specialty retail customers, and the absence of inventory pipeline sales to a key specialty retailer.

Olaplex's Q4 2022 net sales declined by 21.5% to $130.7 million compared to Q4 2021. The company is focusing on resetting its base and investing in core areas like sales, marketing, and education for future growth.

Olaplex reported a 9.2% increase in net sales to $176.5 million for the third quarter of 2022. The growth was primarily driven by a 60.1% increase in the Specialty Retail channel and a 27.8% increase in international net sales. Diluted EPS was $0.09, compared to $0.08 in the third quarter of 2021.

Olaplex Holdings, Inc. reported a 38.6% increase in net sales for the second quarter of 2022, reaching $210.9 million. The company's diluted EPS was $0.13, and adjusted diluted EPS was $0.14. Olaplex reaffirmed its fiscal year 2022 guidance, reflecting confidence in its strategy and market position.

Olaplex reported a strong start to 2022 with a 57.6% increase in net sales, driven by growth across all channels and geographies. The company launched new products and expanded distribution, while reaffirming its fiscal year 2022 guidance for net sales, adjusted net income, and adjusted EBITDA.

Olaplex Holdings, Inc. announced financial results for the third quarter ended September 30, 2021, with net sales increasing by 81% to $161.6 million compared to the third quarter of 2020. The company also completed its initial public offering during the quarter.